See All Slides -

Slides

Presentation TCT 2016

2016 DAPT Update: Evidence and Guidelines

Presenter: Sripal Bangalore, George D. Dangas, Adnan K. Chhatriwalla

November 01, 2016

Presentation TCT 2016

Impact of SFA Lesion Complexity: DCB Outcomes in the "Real-world"

Presenter: Koen Deloose, William A. Gray

November 01, 2016

Presentation TCT 2016

NIRS Detection of Vulnerable Plaque: The Story Is Intensifying

Presenter: John A. Ambrose, Peter H. Stone, David Erlinge

November 01, 2016

Presentation TCT 2016

Preprocedural Planning Prior to Transcatheter Mitral Valve Interventions

Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min

November 01, 2016

Presentation TCT 2016

When to Stop Being an Interventionalist: Age Alone?

Presenter: David O. Williams, Augusto D. Pichard

November 01, 2016

Presentation TCT 2016

How Much Radiation Do I Use Compared to Others? Review of Reference Levels and QA Policies

Presenter: Stephen Balter, Donald L. Miller

November 01, 2016

Presentation TCT 2016

Hot Topic #2: Lipid Lowering Targets and the Potential Role of the PSCK9 Inhibitors in Routine Clinical Practice

Presenter: Bernard J. Gersh, Felix Mahfoud, Evan A. Stein

November 01, 2016

Presentation TCT 2016

"DCB Efficacy In the SFA: Class-Effect or Device Specific"

Presenter: Koen Deloose, William A. Gray, Salvatore Cassese

November 01, 2016

Presentation TCT 2016

Learning the Business of Interventional Cardiology

Presenter: Ehtisham Mahmud, Manish A. Parikh, Ethan C Korngold

November 01, 2016

Presentation TCT 2016

Planning and Performing TAVR in the Patient With CKD

Presenter: Somjot S. Brar, Richard Solomon, Anuj Gupta

November 01, 2016

Advertisement

Slides

2016 DAPT Update: Evidence and Guidelines

Impact of SFA Lesion Complexity: DCB Outcomes in the "Real-world"

NIRS Detection of Vulnerable Plaque: The Story Is Intensifying

Preprocedural Planning Prior to Transcatheter Mitral Valve Interventions

When to Stop Being an Interventionalist: Age Alone?

How Much Radiation Do I Use Compared to Others? Review of Reference Levels and QA Policies

Hot Topic #2: Lipid Lowering Targets and the Potential Role of the PSCK9 Inhibitors in Routine Clinical Practice

"DCB Efficacy In the SFA: Class-Effect or Device Specific"

Learning the Business of Interventional Cardiology

Planning and Performing TAVR in the Patient With CKD

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content